Detalles de la búsqueda
1.
Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment.
Noro Psikiyatr Ars
; 60(1): 23-27, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36911568
2.
Erratum: Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment.
Noro Psikiyatr Ars
; 60(2): 190, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37287556
3.
Generation and characterization of human induced pluripotent stem cell line METUi001-A from a 25-year-old male patient with relapsing-remitting multiple sclerosis.
Stem Cell Res
; 53: 102370, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34087999
4.
Comparison of Brain Atrophy, Cognition and Optical Coherence Tomography Results Between Multiple Sclerosis Patients and Healthy Controls.
Noro Psikiyatr Ars
; 55(1): 3-8, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30042634
5.
Sporadic Creutzfeldt-Jacob Disease: An 8-Year Experience from a Single Center in Turkey.
Noro Psikiyatr Ars
; 50(4): 306-311, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28360562
6.
Structural and neurochemical evaluation of the brain and pons in patients with Wilson's disease.
Jpn J Radiol
; 28(9): 663-71, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21113750
Resultados
1 -
6
de 6
1
Próxima >
>>